Cover Image

Recent advances in vaccine and immunotherapy for COVID-19

The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel vir...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali A. Rabaan (Author), Shamsah H. Al-Ahmed (Author), Ranjit Sah (Author), Jaffar. A. Al-Tawfiq (Author), Ayman M. Al-Qaaneh (Author), Lamiaa H. Al-Jamea (Author), Alexander Woodman (Author), Manaf Al-Qahtani (Author), Shafiul Haque (Author), Harapan Harapan (Author), D. Katterine Bonilla-Aldana (Author), Pavan Kumar (Author), Kuldeep Dhama (Author), Alfonso J. Rodriguez-Morales (Author)
Format: Book
Published: Taylor & Francis Group, 2020-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.
Item Description:2164-5515
2164-554X
10.1080/21645515.2020.1825896

Similar Items